Meeting Impression: A novel approach for high CV risk patients with diabetes: The potential for epigenetics

06/09/2016

A Meeting Impression from a EBAC accredited satellite symposium held at ESC 2016 in Rome that explored a novel approach to reduce residual CV risk, namely BET inhibition

News - Sep. 6, 2016

Download Meeting Impression in PDF

Register

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free